Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-c…
Nosaka K; Kusumoto S; Nakano N; Choi I; Yoshimitsu M; Imaizumi Y; Hidaka M; Sasaki H; Makiyama J; Ohtsuka E; Jo T; Ogata M; Ito A; Yonekura K; Tatetsu H; Kato T; Kawakita T; Suehiro Y; Ishitsuka K; Iida S; Matsutani T; Utsunomiya A; Ueda R; Ishida T.
Br J Haematol
(Unknown)
Published: 2021
Epstein-Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV.
Venturini C; Houldcroft CJ; Lazareva A; Wegner F; Morfopoulou S; Amrolia PJ; Golwala Z; Rao A; Marks SD; Simmonds J; Yoshikawa T; Farrell PJ; Cohen JI; Worth AJ; Breuer J.
Br J Haematol
(Unknown)
Published: 2021
Minimal residual disease (MRD) detection in acute lymphoblastic leukaemia based on fusion genes and genomic deletions: …
Kuiper RP; Hoogeveen PG; Bladergroen R; van Dijk F; Sonneveld E; van Leeuwen FN; Boer J; Sergeeva I; Feitsma H; den Boer ML; van der Velden VHJ.
Br J Haematol
(Unknown)
Published: 2021
Updated results of the placebo-controlled, phase III JAKARTA trial of fedratinib in patients with intermediate-2 or hig…
Pardanani A; Tefferi A; Masszi T; Mishchenko E; Drummond M; Jourdan E; Vannucchi A; Jurgutis M; Ribrag V; Rambaldi A; Koh LP; Rose S; Zhang J; Harrison C.
Br J Haematol
(Unknown)
Published: 2021
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Oluwole OO; Bouabdallah K; Muñoz J; De Guibert S; Vose JM; Bartlett NL; Lin Y; Deol A; McSweeney PA; Goy AH; Kersten MJ; Jacobson CA; Farooq U; Minnema MC; Thieblemont C; Timmerman JM; Stiff P; Avivi I; Tzachanis D; Kim JJ; Bashir Z; McLeroy J; Zheng Y; Rossi JM; Johnson L; Goyal L; van Meerten T.
Br J Haematol
(Unknown)
Published: 2021
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease…
Moia R; Favini C; Ferri V; Forestieri G; Terzi Di Bergamo L; Schipani M; Sagiraju S; Andorno A; Rasi S; Adhinaveni R; Talotta D; Al Essa W; De Paoli L; Margiotta Casaluci G; Patriarca A; Boldorini RL; Rossi D; Gaidano G.
Br J Haematol
(Unknown)
Published: 2021
Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma.
Avivi I; Balaban R; Shragai T; Sheffer G; Morales M; Aharon A; Lowenton-Spier N; Trestman S; Perry C; Benyamini N; Mittelman M; Tabib Y; Bar Lev T; Zavaro M; Herishanu Y; Luttwak E; Cohen YC.
Br J Haematol
(Unknown)
Published: 2021
Time to rethink haemoglobin threshold guidelines in sickle cell disease.
Br J Haematol
(Unknown)
Published: 2021
Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de …
Borjas Howard J; Ruiz-Sada P; de Leeuw K; López-Jiménez L; Font C; Marchena PJ; Madridano O; Debourdeau P; Meijer K; Monreal M; Registro Informatizado de Enfermedad TromboEmbólica (RIETE) Investigators.
Br J Haematol
(Unknown)
Published: 2021
Evaluation of the pharmacokinetics of prednisolone in paediatric patients with acute lymphoblastic leukaemia treated ac…
Sassen SDT; Mathôt RAA; Pieters R; de Haas V; Kaspers GJL; van den Bos C; Tissing WJE; Te Loo DMWW; Bierings MB; van der Sluis IM; Zwaan CM.
Br J Haematol
(Unknown)
Published: 2021
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics.
Harrison SJ; Perrot A; Alegre A; Simpson D; Wang MC; Spencer A; Delimpasi S; Hulin C; Sunami K; Facon T; Vlummens P; Yong K; Campana F; Inchauspé M; Macé S; Risse ML; van de Velde H; Richardson P.
Br J Haematol
(Unknown)
Published: 2021
Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin h…
Genuardi E; Romano G; Beccuti M; Alessandria B; Mannina D; Califano C; Rota Scalabrini D; Cortelazzo S; Ladetto M; Ferrero S; Calogero RA; Cordero F.
Br J Haematol
(Unknown)
Published: 2021